Pharmahungary Group is an ISO 9001:2015 certified global R&D service provider company providing preclinical and clinical R&D services since 2001. 

1.    Preclinical R&D services: focusing on but not restricted to cardiovascular (myocardial infarction, heart failure, arrhythmias), metabolic (diabetes, insulin resistance, hyperlipidemia, atherosclerosis, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH)), renal (uremia, acute pancreatitis), inflammation (sepsis, septic shock, chronic arthritis, traumatic neuropathy, allergic contact dermatitis, ulcerative colitis, acute interstitial pneumonitis, Psoriasiform Dermatitis), oncology (Triple Negative Breast Cancer (TNBC), Small Cell Lung Cancer (SCLC)), and musculoskeletal (sarcopenia) diseases. Disease modelf from in vitro to in vivo studies including large animals as well as various ex vivo models and bioinformatics analysis capabilities are available. We also run custom designed combined disease animal models.
 
2.    Clinical R&D services: full management of clinical trials with Medical Devices including In Vitro Diagnostics, ATMPs, Investigator Initiated Trials, and niche trials that need strong  scientific and regulatory consulting, e.g. clinical trials on sensitive patient population.